Gene expression of RAAS molecules is modulated by PPARγ, and to a lesser extent by PPARα, making the ligands of these transcription factors potential blood pressure modulating drugs in RAAS-dependent hypertension [3, 21, 70]. The gene discussed is PPARG; the disease is Hypertension.